| 07/02 | Fresh Tracks Therapeutics, Inc. : Change in Directors or Principal Officers, Financial Sta.. |  |
| 02/02 | Fresh Tracks Therapeutics : Company Overview Presentation | |
| 27/01 | Fresh Tracks Therapeutics, Inc. : Change in Directors or Principal Officers, Regulation FD.. | |
| 27/01 | Fresh Tracks Therapeutics Names Andrew Sklawer CEO | |
| 27/01 | Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief Executive Officer | |
| 27/01 | Fresh Tracks Therapeutics, Inc. Announces Executive Changes, Effective February 1, 2023 | |
| 12/01 | Fresh Tracks Therapeutics Announces Publication of Preclinical Data for FRTX-02, a Pote.. | |
| 12/01 | Fresh Tracks Therapeutics Announces Publication of Preclinical Data for FRTX-02, a Pote.. | |
| 11/01 | Fresh Tracks Therapeutics Announces Publication of Preclinical Data for FRTX-02, a Pote.. | |
| 11/01 | Fresh Tracks Therapeutics, Inc. Announces Publication of Preclinical Data for FRTX-02 | |
| 04/01 | Fresh Tracks Therapeutics : Company Overview Presentation | |
| 2022 | FRESH TRACKS THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND.. | |
| 2022 | Fresh Tracks Therapeutics : Q3 Earnings Snapshot | |
| 2022 | Earnings Flash (BBI) FRESH TRACKS THERAPEUTICS Posts Q3 Revenue $0.5M | |
| 2022 | Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine.. | |
| 2022 | Fresh Tracks Therapeutics Reports Third Quarter 2022 Financial Results and Provides Cor.. | |
| 2022 | Fresh Tracks Therapeutics to Report Third Quarter 2022 Financial Results and Provide a .. | |
| 2022 | Fresh Tracks Therapeutics, Inc. : Change in Directors or Principal Officers, Financial Sta.. | |
| 2022 | Fresh Tracks Therapeutics Appoints Deepak Chadha to the Additional Position of Chief Op.. | |
| 2022 | Fresh Tracks Therapeutics Begins Multiple Ascending Dose Portion of Inflammatory Diseas.. | |
| 2022 | Fresh Tracks Therapeutics Initiates Multiple Ascending Dose Portion of Phase 1 Study of.. | |
| 2022 | Fresh Tracks Therapeutics Initiates Multiple Ascending Dose Portion of Phase 1 Study of.. | |
| 2022 | Fresh Tracks Therapeutics, Inc. : Amendments to Articles of Inc. or Bylaws; Change in Fisc.. | |
| 2022 | Brickell Biotech, Inc. has Changed its Name to Fresh Tracks Therapeutics, Inc | |
| 2022 | Brickell Biotech, Inc. will Change its Name to Fresh Tracks Therapeutics, Inc | |
| 2022 | Brickell Biotech Changes Name to Fresh Tracks Therapeutics | |
| 2022 | Brickell Biotech Announces Corporate Rebranding to Fresh Tracks Therapeutics | |
| 2022 | Fresh Tracks Therapeutics : Company Overview Presentation | |
| 2022 | Updates to Management's Discussion and Analysis of Financial Condition and
Results of O.. | |
| 2022 | Brickell Biotech, Inc. : Non-Reliance on Previous Financials, Audits or Interim Review (fo.. | |
| 2022 | Brickell Biotech, Inc. : Notice of Delisting or Failure to Satisfy a Continued Listing Rul.. | |
| 2022 | BRICKELL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND.. | |
| 2022 | Brickell : Q2 Earnings Snapshot | |
| 2022 | Brickell Biotech : Reports Second Quarter 2022 Financial Results and Provides Corporate Up.. | |
| 2022 | Brickell Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months E.. | |
| 2022 | Brickell Biotech Reports Second Quarter 2022 Financial Results and Provides Corporate U.. | |
| 2022 | Brickell Biotech to Report Second Quarter 2022 Financial Results and Provide a Corporat.. | |
| 2022 | Brickell Biotech, Inc. : Change in Directors or Principal Officers, Amendments to Articles.. | |
| 2022 | Brickell Biotech, Inc. Announces Resignation of Dennison T. Veru from the Board of Dire.. | |
| 2022 | Brickell Biotech Regains Compliance With Nasdaq's Minimum Bid Price Requirement for Con.. | |
| 2022 | Brickell Biotech : Regains Compliance with Nasdaq Minimum Bid Price Requirement - Form 8-K | |
| 2022 | Brickell Biotech, Inc. : Other Events, Financial Statements and Exhibits (form 8-K) | |
| 2022 | Brickell Biotech Regains Compliance with Nasdaq Minimum Bid Price Requirement | |
| 2022 | Brickell Biotech to Participate at William Blair Biotech Focus Conference 2022 | |
| 2022 | Brickell Biotech : Announces 1-For-45 Reverse Stock Split - Form 8-K | |
| 2022 | Brickell Biotech, Inc. : Material Modification to Rights of Security Holders, Amendments t.. | |
| 2022 | Brickell Biotech Announces 1-For-45 Reverse Stock Split | |
| 2022 | Brickell Biotech : Delisting/Failure to Satisfy Listing Rule/Transfer of Listing - Form 8-.. | |
| 2022 | Brickell Biotech, Inc. : Notice of Delisting or Failure to Satisfy a Continued Listing Rul.. | |
| 2022 | Brickell Biotech Chief Accounting Officer Resigns; Successor Named | |
| 2022 | Brickell Biotech, Inc. : Change in Directors or Principal Officers, Financial Statements a.. | |
| 2022 | Brickell Biotech, Inc. Announces Executive Changes | |
| 2022 | Brickell Biotech, Inc. : Entry into a Material Definitive Agreement, Unregistered Sale of .. | |
| 2022 | Brickell Biotech Begins Dosing in Phase 1 Trial of Atopic Dermatitis Treatment | |
| 2022 | Brickell Biotech Doses First Subject in Phase 1 Study of DYRK1A Inhibitor BBI-02 | |
| 2022 | Brickell Biotech Doses First Subject in Phase 1 Study of DYRK1A Inhibitor BBI-02 | |
| 2022 | Brickell Biotech, Inc. : Change in Directors or Principal Officers, Submission of Matters .. | |
| 2022 | North American Morning Briefing: Stock Futures -3- | |
| 2022 | Brickell : Q1 Earnings Snapshot | |
| 2022 | BRICKELL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND.. | |
| 2022 | Brickell Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2.. | |
| 2022 | Earnings Flash (BBI) BRICKELL BIOTECH Posts Q1 Revenue $92,000 | |
| 2022 | Brickell Biotech Reports First Quarter 2022 Financial Results and Provides Corporate Up.. | |
| 2022 | Brickell Biotech to Report First Quarter 2022 Financial Results and Provide a Corporate.. | |
| 2022 | Wall Street Set for Higher Open Ahead of Fed Funds Rate Announcement, ISM's Services In.. | |
| 2022 | Top Premarket Gainers | |
| 2022 | Botanix Pharmaceuticals Acquires Assets for Excessive Underarm Sweating Treatment | |
| 2022 | Brickell Biotech, Inc. : Submission of Matters to a Vote of Security Holders, Regulation F.. | |
| 2022 | Brickell Biotech, Inc. : Entry into a Material Definitive Agreement, Termination of a Mate.. | |
| 2022 | Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals | |
| 2022 | Brickell Biotech Announces Adjournment of Annual Meeting of Stockholders | |
| 2022 | BRICKELL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND.. | |
| 2022 | Brickell : Q4 Earnings Snapshot | |
| 2022 | Brickell Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 20.. | |
| 2022 | Brickell Biotech : Reports Fourth Quarter and Full Year 2021 Financial Results and Provide.. | |
| 2022 | Earnings Flash (BBI) BRICKELL BIOTECH Reports Q4 Revenue $104,000, vs. Street Est of $0.. | |
| 2022 | Brickell Biotech, Inc. Reports Earnings Results for the Fourth Quarter Ended December 3.. | |
| 2022 | Brickell Biotech Reports Fourth Quarter and Full Year 2021 Financial Results and Provid.. | |
| 2022 | Brickell Biotech Selected for a Late-Breaking Oral Presentation of US Phase 3 Pivotal C.. | |
| 2022 | Brickell Biotech to Report Fourth Quarter and Full Year 2021 Financial Results and Prov.. | |
| 2022 | Brickell Biotech Obtains Exclusive Rights to Carna Biosciences' Inhibitor Portfolio Tar.. | |
| 2022 | Brickell Biotech : Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitors.. | |
| 2022 | Brickell Biotech, Inc. : Entry into a Material Definitive Agreement (form 8-K) | |
| 2022 | Brickell Biotech, Inc. Enters into an Exclusive License Agreement with Carna Bioscience.. | |
| 2022 | Brickell Biotech Acquires Exclusive Global Rights to Portfolio of Novel STING Inhibitor.. | |
| 2022 | Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, .. | |
| 2022 | Top Midday Gainers | |
| 2022 | Top Premarket Gainers | |
| 2021 | Brickell Biotech, Inc. : Notice of Delisting or Failure to Satisfy a Continued Listing Rul.. | |
| 2021 | Brickell : Q3 Earnings Snapshot | |
| 2021 | BRICKELL BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND.. | |
| 2021 | Earnings Flash (BBI) BRICKELL BIOTECH Reports Q3 Revenue $0.1M, vs. Street Est of $0.15.. | |
| 2021 | Brickell Biotech Reports Third Quarter 2021 Financial Results and Provides Corporate Up.. | |
| 2021 | Brickell Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months E.. | |
| 2021 | Brickell Biotech, Inc. : Results of Operations and Financial Condition (form 8-K) | |
| 2021 | Brickell Biotech, Inc. Expands Leadership Team by Appointing Dr. Monica Luchi as Chief .. | |
| 2021 | Brickell Biotech Reports Third Quarter 2021 Financial Results and Provides Corporate Up.. | |
| 2021 | Brickell Biotech Announces Proposed Underwritten Public Offering of Common Stock - Form.. | |
| 2021 | Brickell Biotech, Inc. : Entry into a Material Definitive Agreement (form 8-K) | |
| 2021 | Brickell Biotech to Report Third Quarter 2021 Financial Results and Provide a Corporate.. | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Rapport
